tyrosine and Neuroendocrine Tumors

tyrosine has been researched along with Neuroendocrine Tumors in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Grineva, E; Mitrofanova, L; Ryzhkova, D; Schlyakhto, E; Tsoy, U1
Cantone, MC; Dicitore, A1
Reubi, JC; Waser, B1
Abe, M; Akiba, J; Ikezono, Y; Iwamoto, H; Koga, H; Masuda, A; Nakamura, T; Sakaue, T; Torimura, T; Tsuruta, O; Wada, F; Yano, H; Yoshida, T1
Delle Fave, G; Di Florio, A; Jensen, RT; Moreno, P; Sancho, V1
Aghi, MK; Brumwell, AN; Chapman, HA; Jablons, DM; Kwan, I; McDonald, DM; Sennino, B; Tan, K; Ulsamer, A; Wei, Y; Xi, Y1
DeJesus, OT; Flores, LG; Murali, D; Nickles, RJ; Roberts, AD1
Angelberger, P; Dudczak, R; Füger, B; Kletter, K; Kurtaran, A; Leimer, M; Li, SR; Novotny, C; Patri, P; Raderer, M; Traub, T; Virgolini, I; Wogritsch, S1

Reviews

1 review(s) available for tyrosine and Neuroendocrine Tumors

ArticleYear
Dual-tracer PET/CT imaging to determine tumor heterogeneity in a patient with metastatic ACTH-secreting neuroendocrine neoplasm: A case report and literature review.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Adrenocorticotropic Hormone; Biological Products; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Somatostatin; Tyrosine

2022

Other Studies

7 other study(ies) available for tyrosine and Neuroendocrine Tumors

ArticleYear
Targeting receptor tyrosine kinases in neuroendocrine neoplasm: what's going on with lung carcinoids?
    Minerva endocrinology, 2022, Volume: 47, Issue:3

    Topics: Carcinoid Tumor; Carcinoma, Neuroendocrine; Humans; Lung; Lung Neoplasms; Neuroendocrine Tumors; Tyrosine

2022
Triple-peptide receptor targeting in vitro allows detection of all tested gut and bronchial NETs.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:4

    Topics: Autoradiography; Bronchial Neoplasms; Glucagon-Like Peptide-1 Receptor; Humans; Insulinoma; Iodine Radioisotopes; Ligands; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Protein Binding; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Receptors, Peptide; Receptors, Somatostatin; Tyrosine

2015
Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1.
    Molecular cancer research : MCR, 2017, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Biomarkers, Tumor; Cell Line, Tumor; Doublecortin-Like Kinases; Epithelial-Mesenchymal Transition; Female; Focal Adhesion Kinase 1; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice, Inbred BALB C; Middle Aged; Neoplastic Stem Cells; Neuroendocrine Tumors; Pancreatic Neoplasms; Protein Serine-Threonine Kinases; Tyrosine; Xenograft Model Antitumor Assays

2017
Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor.
    Biochimica et biophysica acta, 2013, Volume: 1833, Issue:3

    Topics: Adenoma, Islet Cell; Animals; Blotting, Western; Cell Proliferation; Epidermal Growth Factor; ErbB Receptors; Gastrointestinal Hormones; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Phosphorylation; Rats; Reactive Oxygen Species; Signal Transduction; Somatostatinoma; Transcriptional Activation; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tyrosine

2013
Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia.
    Oncogene, 2013, Oct-17, Volume: 32, Issue:42

    Topics: Adenocarcinoma; Adenoma; Adenoma, Islet Cell; Animals; Antibodies, Neutralizing; beta Catenin; Cell Hypoxia; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mice; Mice, Transgenic; Neuroendocrine Tumors; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Smad2 Protein; src-Family Kinases; Tyrosine; Vascular Endothelial Growth Factor A

2013
Aromatic L-amino acid decarboxylase (AAAD) inhibitors as carcinoid tumor-imaging agents: synthesis of 18F-labeled alpha-fluoromethyl-6-fluoro-m-tyrosine (FM-6-FmT).
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2003, Volume: 59, Issue:4

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Carcinoid Tumor; Fluorine Radioisotopes; Humans; Isotope Labeling; Neuroendocrine Tumors; Protein Binding; Radioligand Assay; Radiopharmaceuticals; Tomography, Emission-Computed; Tyrosine

2003
Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12 Suppl 2

    Topics: Adenocarcinoma; Adult; Carcinoid Tumor; Fluorodeoxyglucose F18; Heterocyclic Compounds; Humans; Intestinal Neoplasms; Ligands; Lung Neoplasms; Lymphoma; Neuroendocrine Tumors; Octreotide; Peptides, Cyclic; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed; Tyrosine

2001